BioProject

Protozoan pathogens that cause leishmaniasis in humans are relatively refractory to genetic manipulation. More...

Protozoan pathogens that cause leishmaniasis in humans are relatively refractory to genetic manipulation. In this work we implemented the CRISPR-Cas9 system in Leishmania parasites and demonstrated its efficient use for genome editing. The Cas9 endonuclease was expressed under the control of the DHFR-TS promoter and the single guide RNA was produced under the control of the U6snRNA promoter and terminator. As a proof of concept we chose to knockout a tandemly repeated gene family, the paraflagellar rod-2 locus. We were able to obtain null mutants in a single round of transfection. In addition, we confirmed the absence of off-target editions by whole genome sequencing of two independent clones. Our work demonstrates that CRISPR-Cas9-mediated gene knockout represents a major improvement in comparison with existing methods. Beyond gene knockout, this genome editing tool opens avenues for a multitude of functional studies to speed up research on leishmaniasis. Less...